Accuitis Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1M
Latest Deal Amount
  • Investors
  • 5

Accuitis General Information


Developer and marketer of pharmaceuticals intended for dermatological diseases. The company's therapy contains proteasome inhibitor for the treatment of rosacea and other topical skin diseases, providing patients drugs for the treatment of rosacea.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 1005 Alderman Drive
  • Suite 104
  • Alpharetta, GA 30041
  • United States
+1 (678) 000-0000

Accuitis Timeline

Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Accuitis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 31-Aug-2018 $1M 00.000 Completed Generating Revenue
2. Later Stage VC 05-Sep-2017 00.000 00.000 Completed Startup
1. Grant Completed Startup
To view Accuitis’s complete valuation and funding history, request access »

Accuitis Executive Team (4)

Name Title Board Seat Contact Info
Richard Coulon Co-Founder, President Chief Executive Officer & Board Member
Michael Shippel Chief Financial Officer & Board Member
Mark Jackson MD Medical Consultant
Jack Arbiser Ph.D Co-Founder & Chief Innovation Officer
To view Accuitis’s complete executive team members history, request access »

Accuitis Board Members (6)

Name Representing Role Since
Geoffrey Meacham Ph.D Bio/Med Investor Network Board Member 000 0000
Michael Shippel Accuitis Chief Financial Officer & Board Member 000 0000
Richard Coulon Accuitis Co-Founder, President Chief Executive Officer & Board Member 000 0000
Robert Thomas Ph.D Self Board Member 000 0000
Stephen Martin JD Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Accuitis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accuitis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Atlanta Technology Angels Angel Group Minority 000 0000 000000 0
Bio/Med Investor Network Angel Group Minority 000 0000 000000 0
Georgia Research Alliance Government 000 0000 000000 0
GRA Venture Fund Venture Capital Minority 000 0000 000000 0
Robert Thomas Angel (individual) Minority 000 0000 000000 0
To view Accuitis’s complete investors history, request access »